EMERGEX Trademark

Trademark Overview


On Monday, June 25, 2018, a trademark application was filed for EMERGEX with the United States Patent and Trademark Office. The USPTO has given the EMERGEX trademark a serial number of 79245388. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Friday, December 22, 2023. This trademark is owned by EMERGEX VACCINES HOLDING LIMITED. The EMERGEX trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations for the treatment of viral and bacterial infectious diseases; drugs for medical purposes, namely, immunotherapeutic drugs for viral and bacterial infectious diseases; pharmaceutical substances for the treatment of viral and bacterial infectious diseases; peptides for pharmaceutical use, namely, peptides for the treatment of viral and bacterial infectious diseases; drug delivery agents in the form of nanoparticles that facilitate the delivery of pharmaceutical preparations; vaccines

Scientific research for medical purposes; pharmaceutical drug research and development services; medical and pharmacological research services; research and development in the pharmaceutical and biotechnology fields; providing medical and scientific research information in the fields of pharmaceutical and clinical trials; conducting clinical trials; information, advisory and consultancy services relating to the aforesaid

General Information


Serial Number79245388
Word MarkEMERGEX
Filing DateMonday, June 25, 2018
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateFriday, December 22, 2023
Registration Number5876504
Registration DateTuesday, October 8, 2019
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 23, 2019

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of viral and bacterial infectious diseases; drugs for medical purposes, namely, immunotherapeutic drugs for viral and bacterial infectious diseases; pharmaceutical substances for the treatment of viral and bacterial infectious diseases; peptides for pharmaceutical use, namely, peptides for the treatment of viral and bacterial infectious diseases; drug delivery agents in the form of nanoparticles that facilitate the delivery of pharmaceutical preparations; vaccines
Pseudo MarkEMERGE X
Goods and ServicesScientific research for medical purposes; pharmaceutical drug research and development services; medical and pharmacological research services; research and development in the pharmaceutical and biotechnology fields; providing medical and scientific research information in the fields of pharmaceutical and clinical trials; conducting clinical trials; information, advisory and consultancy services relating to the aforesaid

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeH - NOT AVAILABLE
Class Status DateFriday, December 22, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status CodeH - NOT AVAILABLE
Class Status DateFriday, December 22, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEMERGEX VACCINES HOLDING LIMITED
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressGB

Party NameEMERGEX VACCINES HOLDING LIMITED
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressGB

Party NameEMERGEX VACCINES HOLDING LIMITED
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGB

Trademark Events


Event DateEvent Description
Saturday, January 6, 2024NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Saturday, January 6, 2024DEATH OF INTERNATIONAL REGISTRATION
Saturday, September 2, 2023NEW REPRESENTATIVE AT IB RECEIVED
Wednesday, September 14, 2022CANCELLATION INSTITUTED NO. 999999
Saturday, June 26, 2021NEW REPRESENTATIVE AT IB RECEIVED
Friday, February 21, 2020FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, January 31, 2020FINAL DISPOSITION NOTICE SENT TO IB
Friday, January 31, 2020FINAL DISPOSITION PROCESSED
Wednesday, January 8, 2020FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Friday, October 25, 2019NEW REPRESENTATIVE AT IB RECEIVED
Tuesday, October 8, 2019REGISTERED-PRINCIPAL REGISTER
Friday, August 2, 2019NOTIFICATION PROCESSED BY IB
Tuesday, July 23, 2019PUBLISHED FOR OPPOSITION
Wednesday, July 17, 2019NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, July 17, 2019NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, July 3, 2019NOTICE OF PUBLICATION
Monday, June 10, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, June 6, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, June 6, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, June 6, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, December 28, 2018REFUSAL PROCESSED BY IB
Friday, December 7, 2018NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, December 7, 2018REFUSAL PROCESSED BY MPU
Friday, November 23, 2018APPLICATION FILING RECEIPT MAILED
Thursday, November 22, 2018NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, November 21, 2018NON-FINAL ACTION WRITTEN
Monday, November 19, 2018ASSIGNED TO EXAMINER
Monday, November 19, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, November 15, 2018SN ASSIGNED FOR SECT 66A APPL FROM IB